# Commission decision of 27 March 2007 on the allocation of quantities of controlled substances allowed for essential uses in the Community in 2007 under Regulation (EC) No 2037/2000 of the European Parliament and of the Council (notified under document number C(2007) 1285) (Only the Danish, Dutch, English, Estonian, French, German, Italian, Slovenian and Spanish texts are authentic) (Text with EEA relevance) (2007/211/EC), Annex V: Essential laboratory uses

Extent: E+W+S+N.I.

Quota of controlled substances of Group IV that may be used for laboratory and analytical uses, are allocated to:
Acros Organics (BE)
Bie & Berntsen A-S (DK)
Carlo Erba Reactifs-SDS (FR)
Health Protection Inspectorate-Laboratories (EE)
Honeywell Specialty Chemicals (DE)
Institut scientifique de service public (ISSeP) (BE)
Mallinckrodt Baker (NL)
Merck KGaA (DE)
Mikro+Polo d.o.o. (SI)
Panreac Química S.A. (ES)
Sanolabor d.d. (SI)
Sigma Aldrich Chimie (FR)
Sigma Aldrich Laborchemikalien (DE)
Sigma Aldrich Logistik (DE)

---
Source: https://www.legislation.gov.uk/eudn/2007/211/annex/V (the official version)
Page: https://openlegislation.uk/eu-decision-2007-211/annex-V
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

